Accès à distance ? S'identifier sur le proxy UCLouvain
Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma
Primary tabs
Document type | Article de périodique (Journal article) – Article de recherche – Clinical Trial, Phase II, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't |
---|---|
Access type | Accès restreint |
Publication date | 2010 |
Language | Anglais |
Journal information | "Journal of Clinical Oncology" - Vol. 28, no. 3, p. 475-480 (2010) |
Peer reviewed | yes |
Publisher | American Society of Clinical Oncology ((United States) Alexandria) |
issn | 0732-183X |
e-issn | 1527-7755 |
Publication status | Publié |
Affiliations |
UCL
- SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie UCL - (SLuc) Unité d'oncologie médicale |
MESH Subject | Treatment Outcome ; Sulfonamides - therapeutic use ; Pyrimidines - therapeutic use ; Middle Aged ; Male ; Kidney Neoplasms - drug therapy - secondary ; Humans ; Female ; Carcinoma, Renal Cell - drug therapy - secondary ; Antineoplastic Agents - therapeutic use ; Angiogenesis Inhibitors - therapeutic use ; Aged, 80 and over ; Aged ; Adult |
Links |
Bibliographic reference | Hutson, Thomas E. ; Davis, Ian D. ; Machiels, Jean-Pascal ; De Souza, Paul L. ; Rottey, Sylvie ; et. al. Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma. In: Journal of Clinical Oncology, Vol. 28, no. 3, p. 475-480 (2010) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/28890 |